Rationale for prostaglandin I2 in bone marrow oedema--from theory to application. - Wikidata - wikimedia - TriplyDB

Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

http://www.wikidata.org/entity/Q36993305

about

Current concepts on osteonecrosis of the femoral head Osteonecrosis of the knee: review Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review Treatment of bone marrow lesions (bone marrow edema).Bone Marrow Lesion: Image, Clinical Presentation, and Treatment.Bone marrow lesions: a universal bone response to injury?Efficiency of iloprost treatment for osseous malperfusion.Magnetic resonance imaging of hip joint cartilage and labrum.Modulation of the intramedullary pressure responses by calcium dobesilate in a rabbit knee model of osteoarthritis.Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate.Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis Efficacy of alendronate for preventing collapse of femoral head in adult patients with nontraumatic osteonecrosis.Comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysis Bone marrow lesions and subchondral bone pathology of the knee.Bone Marrow Edema Syndrome in the Foot and Ankle.A Case of Trapezium Avascular Necrosis Treated Conservatively.Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.Revision surgery after third generation autologous chondrocyte implantation in the knee.

P2860

Q26781891-37BC091A-3139-4077-966F-118A24E25926 Q27014766-37E20052-9C3C-42C8-8F78-4BA4B7DA061E Q27024747-0E3E26F2-532C-47EC-B312-61922EFC2151 Q31030762-0F775140-2FE2-408F-A236-3A9A36581386 Q33670532-8589AE38-9562-4525-9300-37DE9D2A0B4E Q34013884-8A6BA4FC-C4CD-42FF-B2C8-F8C4D5DFA0E8 Q34828186-E507A760-E490-4C17-8B93-93CE6263C590 Q35505703-E737E4DA-26CF-4177-BC09-9E9351150FA7 Q35624452-5DCC861D-55AB-4365-B58F-EE442E9E0A84 Q36254554-FAAB883B-FDB9-475A-ABC9-A5E1244BA095 Q36766489-3497A0B6-8F61-44A4-B3FB-C3B705C721B5 Q38298725-380427E5-7C0F-42BC-9272-4A9AEB645D1E Q38541287-67098BCB-C3A2-4ACB-84E7-CDDA0FD036CC Q38807786-24D7E1CE-F4DF-4200-B958-9EF0CB90330D Q38944515-69C5D463-642D-4A34-91AD-26209082FF8F Q42215325-0FACC331-63B2-479D-B81C-0E6B9405A8FD Q44764892-2DE13FB7-D9BA-4709-A597-34DF47475689 Q49077175-D3377028-BC11-49C8-B79D-7765A2252341

P2860

Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

http://www.wikidata.org/entity/Q36993305

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

@en

type

label

Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

@en

prefLabel

Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

@en

P1433

Q36993305-3511145E-899A-4EBF-ADC9-B2D144F19B3A

P1476

Q36993305-66F096C2-716D-4526-9FFA-2D8DE6CFC3B9

P2093

Q36993305-26DDC1A9-3B10-4A07-A85F-69D9BFC90596

Q36993305-37F6D006-57CC-4AFC-BA35-7B4BA9B90F45

Q36993305-3BBBE89F-1F97-478C-AE6C-EF1609F17FD5

Q36993305-44B9AD2C-CD53-4B1B-AE41-6F2B2A9B2F68

Q36993305-501D9E8E-57B5-4405-90ED-6C9F3A62F16D

Q36993305-92BC7115-BD15-40CE-8169-92A41BB99717

Q36993305-C2527FDE-D3F2-4DA9-AC26-AE2FD938E768

Q36993305-D38C8525-182F-493C-94BE-583A0346D630

P2860

Q36993305-07121905-DB2F-4822-BC3A-CFCB3018831B

Q36993305-087052B1-2CFA-4FDE-B0F7-20B63F8FDAA5

Q36993305-1721F14A-D59A-4F37-992F-33F12F4F35FB

Q36993305-1CC9C069-392A-4598-91E9-1E68A4269E54

Q36993305-1E17EA67-807D-4D4A-9F23-AC97884C4CE9

Q36993305-20124564-9D84-44CF-BBDA-2FFCFFEDC373

Q36993305-33893DEF-C8AE-4800-9B5F-B907B2DA9504

Q36993305-3725ABF3-B36C-4E35-8455-B6647BF31FCD

Q36993305-37F14122-E571-499C-8CCE-1BFE9919E1F4

Q36993305-3BC9D0D5-5C71-4326-98F8-563DE468465E

P2888

Q36993305-8388675F-1A46-4928-8388-D09B4D829C4F

P304

Q36993305-17CF6948-63EC-4873-B654-B076F99521E1

P31

Q36993305-3F2AEC6C-2FC1-49C2-B181-13DEC056E579

P356

Q36993305-52CDE85C-8BD8-44BD-8CB6-A8C317B90AA8

P433

Q36993305-080D4F33-8487-4B09-B480-138FED6FA874

P478

Q36993305-93376B90-3C26-4147-B89F-8F48CAD6677A

P577

Q36993305-1B2302B2-9733-4AB1-A68B-63E642675E96

P5875

Q36993305-D98DE58B-1991-49C9-9782-4828269C6724

P698

Q36993305-AB7AAC54-601E-4325-91EF-B16A7582B04D

P932

Q36993305-08D0D6E7-C1FD-42AB-AF32-1E229BC1BE7D

P356

P1433

Arthritis Research and Therapy

P1476

Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

@en

P2093

Christoph Zilkens

http://www.w3.org/2001/XMLSchema#string

Dirk Blondin

http://www.w3.org/2001/XMLSchema#string

Frank Peter Tillmann

http://www.w3.org/2001/XMLSchema#string

Gerd Rüdiger Hetzel

http://www.w3.org/2001/XMLSchema#string

Marcus Jäger

http://www.w3.org/2001/XMLSchema#string

Marcus Mahmoudi

http://www.w3.org/2001/XMLSchema#string

Rüdiger Krauspe

http://www.w3.org/2001/XMLSchema#string

Thomas S Thornhill

http://www.w3.org/2001/XMLSchema#string

P2860

Osteonecrosis in HIV: a case-control study.

Immunohistochemical localization of the prostacyclin receptor (IP) human bone.

Osteonecrosis of the hip in patients with aplastic anemia.

Skeletal aspects of Gaucher disease: a review.

Bone disease after renal transplantation.

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Iloprost for the treatment of bone marrow edema in the hindfoot.

Pharmacological management of aseptic osteonecrosis in children.

MRI of osteonecrosis.

Iloprost inhalation solution for the treatment of pulmonary arterial hypertension.

P2888

P304

R120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2526

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23299057

http://www.w3.org/2001/XMLSchema#string

P698

18834533

http://www.w3.org/2001/XMLSchema#string

P932

2592809

http://www.w3.org/2001/XMLSchema#string